POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen ... - PipelineReview.com (press release)
March 22, 2007| POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen ... PipelineReview.com (press release), Spain - Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. ... |
POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen ... - Genetic Engineering News (press release)
March 22, 2007| POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen ... Genetic Engineering News (press release), NY - Naproxen sodium is indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and juvenile arthritis. ... |
FDA Approves To Review Amended Response Of Pozen's Trexima - Update - Trading Markets
March 22, 2007| FDA Approves To Review Amended Response Of Pozen's Trexima - Update Trading Markets, CA - Naproxen sodium is a non-steroidal anti-inflammatory drug, indicated for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis and ... |
Pozen Reports Trexima Amended Response Accepted For Review By FDA ... - Trading Markets
March 22, 2007| Pozen Reports Trexima Amended Response Accepted For Review By FDA ... Trading Markets, CA - ... prescription medication indicated for the acute treatment of migraine in adults. Naproxen sodium is indicated for the treatment of rheumatoid arthritis, ... |
Diplomat Specialty Pharmacy Provides Tykerb(R) - National Oncology ... - Drug Newswire (press release)
March 22, 2007| Diplomat Specialty Pharmacy Provides Tykerb(R) - National Oncology ... Drug Newswire (press release), CT - Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. The company's Health Services division ... |